Journal
CURRENT OPINION IN BIOTECHNOLOGY
Volume 48, Issue -, Pages 180-186Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.copbio.2017.05.004
Keywords
-
Funding
- University of Texas at El Paso
Ask authors/readers for more resources
It is possible to generate oligonucleotide aptamers for a wide variety of target molecules using a process known as Systematic Evolution of Ligands by Exponential Enrichment. Researchers have successfully generated aptamers which recognize specific metal ions, small chemical compounds, peptides, proteins, saccharides, and even whole cells. Aptamers show much promise as future therapeutics and as drug targeting agents. A particularly active area of aptamer research in the past two years was development of aptamer based cancer therapeutics and development of aptamer based cancer drug delivery systems. Aptamers were also used to address inflammatory diseases, infectious diseases, cardiovascular diseases, and eye diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available